E Amazings
  • Home
  • Automotive
  • Business
  • CBD
  • Crypto
  • Education
  • Entertainment
  • Fashion
  • Finance
  • Health
  • Home Improvement
  • Law \ Legal
  • News
  • Shopping
  • Sports
  • Technology
  • Travel

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Multas a los vendedores ambulantes aumentaron durante el primer año del DCWP

August 9, 2022

Ashish Kacholia stock: This packaging company’s shares hit new lifetime high on Monday; brokerages recommend Buy – check price target

August 9, 2022

Stock Markets: REVEALED! Why world economies fearing recession but India is emerging even stronger

August 9, 2022
Facebook Twitter Instagram
E Amazings
  • Home
  • Automotive
  • Business
  • CBD
  • Crypto
  • Education
  • Entertainment
  • Fashion
  • Finance
  • Health
  • Home Improvement
  • Law \ Legal
  • News
  • Shopping
  • Sports
  • Technology
  • Travel
Facebook Twitter Instagram
E Amazings
You are at:Home»Business»Zydus Lifesciences launches generic version of Sitagliptin for type 2 diabetes
Business

Zydus Lifesciences launches generic version of Sitagliptin for type 2 diabetes

Paul EasterBy Paul EasterJuly 9, 2022No Comments2 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter Pinterest WhatsApp Email


Zydus Lifesciences Ltd on Friday said it has launched the generic version of sitagliptin in India under the brand names Sitaglyn and Siglyn to address type 2 diabetes.

Sitaglyn and Siglyn offer an oral solution to the patients providing ease of convenience and better compliance, the company said in a regulatory filing.

 

These will add on to a comprehensive solution for the management of type 2 diabetes by “providing access to quality care to the patients at an affordable cost, approximately 60 per cent lesser than the originator”, it added.

MSD Pharmaceuticals’ sitagliptin phosphate 10 mg tablets sold under the Januvia brand has a retail price of around Rs 300 per strip of seven tablets.

Zydus Lifesciences Ltd Managing Director Dr Sharvil Patel said, “The addition of Sitaglyn and Siglyn to our diabetes portfolio will give patients access to a world-class oral therapy to help people manage their diabetes better by making it more affordable. Our high quality product will expand the reach of the molecule to patients in India, supported by our wide distribution network.”

Zydus said India’s oral anti-diabetic market is worth Rs 12,500 crore, of which DPP4i (Dipeptidyl peptidase 4 inhibitor) class of anti-diabetics has a share of more than Rs 4,000 crore.

Sitagliptin is the gold standard in the DPP4i category with over 62 per cent market share in the global market, it added.

The company has several brands to address diabetes, including Lipaglyn, Dapaglyn, Vinglyn and Tenglyn.

“With the launch of these brands, Zydus expands its diabetes management offerings for patients and strengthens its presence in the anti-diabetic market,” it added.





Source link

Paul Easter

Related Posts

Ashish Kacholia stock: This packaging company’s shares hit new lifetime high on Monday; brokerages recommend Buy – check price target

By Paul EasterAugust 9, 2022

Stock Markets: REVEALED! Why world economies fearing recession but India is emerging even stronger

By Paul EasterAugust 9, 2022

This American tech company joins ONDC in major boost to government’s effort to reshape e-commerce landscape

By Paul EasterAugust 9, 2022

91% JUMP! Life insurers’ new premium income rises to Rs 39,079 cr in July 2022

By Paul EasterAugust 9, 2022
Add A Comment

Comments are closed.

Our Picks

Multas a los vendedores ambulantes aumentaron durante el primer año del DCWP

By Paul EasterAugust 9, 2022

Ashish Kacholia stock: This packaging company’s shares hit new lifetime high on Monday; brokerages recommend Buy – check price target

By Paul EasterAugust 9, 2022

Stock Markets: REVEALED! Why world economies fearing recession but India is emerging even stronger

By Paul EasterAugust 9, 2022
Recent Posts
  • Multas a los vendedores ambulantes aumentaron durante el primer año del DCWP August 9, 2022
  • Ashish Kacholia stock: This packaging company’s shares hit new lifetime high on Monday; brokerages recommend Buy – check price target August 9, 2022
  • Stock Markets: REVEALED! Why world economies fearing recession but India is emerging even stronger August 9, 2022
  • This American tech company joins ONDC in major boost to government’s effort to reshape e-commerce landscape August 9, 2022
  • 91% JUMP! Life insurers’ new premium income rises to Rs 39,079 cr in July 2022 August 9, 2022
  • AP CFW MLHP Recruitment 2022: Jobs alert! Vacancies notified at cfw.ap.nic.in – How to apply online; know salary August 9, 2022
  • Student Competition Badge Bears Custom Silicon August 9, 2022
Archives
  • August 2022
  • July 2022
  • June 2022
Facebook Twitter Instagram Pinterest TikTok
  • Home
© 2022 E Amazings - All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.